The purpose of this study is to evaluate the presence and manifestations of ocular graft
versus host disease in adults that had hematopoietic stem cell transplantation in the past 3
years at the sheba medical center, Israel. As well as correlate the degree of the
presentation to the therapeutic protocol (chemotherapy and irradiation).